| Adipocytokines: mediators linking adipose tissue, inflammation and immunity H Tilg, AR Moschen Nature reviews immunology 6 (10), 772-783, 2006 | 3824 | 2006 |
| Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis H Tilg, AR Moschen Hepatology 52 (5), 1836-1846, 2010 | 2446 | 2010 |
| Visfatin, an adipocytokine with proinflammatory and immunomodulating properties AR Moschen, A Kaser, B Enrich, B Mosheimer, M Theurl, H Niederegger, ... The Journal of Immunology 178 (3), 1748-1758, 2007 | 1304 | 2007 |
| Inflammatory mechanisms in the regulation of insulin resistance H Tilg, AR Moschen Molecular medicine 14, 222-231, 2008 | 1105 | 2008 |
| NAFLD and diabetes mellitus H Tilg, AR Moschen, M Roden Nature reviews Gastroenterology & hepatology 14 (1), 32-42, 2017 | 798 | 2017 |
| Microbiota and diabetes: an evolving relationship H Tilg, AR Moschen Gut 63 (9), 1513-1521, 2014 | 781 | 2014 |
| European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease JF Rahier, S Ben-Horin, Y Chowers, C Conlon, P De Munter, G D'Haens, ... Journal of Crohn's and Colitis 3 (2), 47-91, 2009 | 669 | 2009 |
| Adiponectin and its receptors in non-alcoholic steatohepatitis S Kaser, A Moschen, A Cayon, A Kaser, J Crespo, F Pons-Romero, ... Gut 54 (1), 117-121, 2005 | 572 | 2005 |
| Insulin resistance, inflammation, and non-alcoholic fatty liver disease H Tilg, AR Moschen Trends in Endocrinology & Metabolism 19 (10), 371-379, 2008 | 565 | 2008 |
| The intestinal microbiota in colorectal cancer H Tilg, TE Adolph, RR Gerner, AR Moschen Cancer cell 33 (6), 954-964, 2018 | 549 | 2018 |
| Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction MM Richardson, JR Jonsson, EE Powell, EM Brunt, ... Gastroenterology 133 (1), 80-90, 2007 | 482 | 2007 |
| Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease C Grander, TE Adolph, V Wieser, P Lowe, L Wrzosek, B Gyongyosi, ... Gut 67 (5), 891-901, 2018 | 439 | 2018 |
| Gut, inflammation and osteoporosis: basic and clinical concepts H Tilg, AR Moschen, A Kaser, A Pines, I Dotan Gut 57 (5), 684-694, 2008 | 347 | 2008 |
| Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases H Tilg, AR Moschen Clinical science 114 (4), 275-288, 2008 | 347 | 2008 |
| IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting AR Moschen, H Tilg, T Raine Nature Reviews Gastroenterology & Hepatology 16 (3), 185-196, 2019 | 303 | 2019 |
| Food, immunity, and the microbiome H Tilg, AR Moschen Gastroenterology 148 (6), 1107-1119, 2015 | 290 | 2015 |
| The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss AR Moschen, A Kaser, B Enrich, O Ludwiczek, M Gabriel, P Obrist, ... Gut 54 (4), 479-487, 2005 | 285 | 2005 |
| Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor α expression AR Moschen, C Molnar, S Geiger, I Graziadei, CF Ebenbichler, H Weiss, ... Gut 59 (9), 1259-1264, 2010 | 279 | 2010 |
| Obesity and the microbiota H Tilg, AR Moschen, A Kaser Gastroenterology 136 (5), 1476-1483, 2009 | 276 | 2009 |
| Inflammation, cytokines and insulin resistance: a clinical perspective V Wieser, AR Moschen, H Tilg Archivum immunologiae et therapiae experimentalis 61, 119-125, 2013 | 268 | 2013 |
Romana R. GernerTechnical University Munich在 mri.tum.de 的电子邮件经过验证
Romana R. GernerTechnical University Munich在 mri.tum.de 的电子邮件经过验证